Myovant Sciences (MYOV) is Initiated by Citigroup to Buy

Myovant Sciences (MYOV) was Initiated by Citigroup to “Buy”. Citigroup advised their investors in a research report released on Nov 21, 2016.

Many Wall Street Analysts have commented on Myovant Sciences. Robert W. Baird Initiated Myovant Sciences on Nov 21, 2016 to “Outperform”, Price Target of the shares are set at $20.Myovant Sciences was Initiated by JMP Securities to “Mkt Outperform” on Nov 21, 2016. Myovant Sciences was Initiated by Citigroup to “Buy” on Nov 21, 2016.

Myovant Sciences

Leave a Reply

Myovant Sciences - Is it time to Sell?

Top Brokerage Firms are advising their investors on Myovant Sciences. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.